Company intelligence / Profile preview

Lucira Health

Emeryville, California, USAlinkedin.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Lucira Health developed the first FDA-authorized at-home molecular COVID‑19 test and later a combined COVID‑19 & Flu home test. Their platform provided lab-quality nucleic acid amplification testing in a disposable device. The company achieved high accuracy rates (~98%) compared to reference PCR methods. In early studies, they also reported promising results for at-home chlamydia/gonorrhea testing. Lucira went public in February 2021 but filed for bankruptcy in early 2023; Pfizer acquired its assets that year and discontinued the business by Q1 of 2025.

Therapeutic areas: Infectious Diseases
Modalities: DeviceMolecular diagnostic test (Nucleic acid amplification test)
Industry: Molecular Diagnostics

Partnerships

Jabil Inc. (manufacturing partner)Sutter HealthCleveland Clinic Floridadistribution partners internationally including Canada/EU/Singapore/Taiwan/Israel

Beyond the preview

Go deeper on Lucira Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucira Health.

Explore the full profile